Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)

CUSIP: 92511W108

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
92,448,158
Total 13F shares
11,327,999
Share change
+2,434,240
Total reported value
$21,748,342
Put/Call ratio
107%
Price per share
$1.92
Number of holders
51
Value change
+$3,203,973
Number of buys
31
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 92511W108?
CUSIP 92511W108 identifies VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
PERCEPTIVE ADVISORS LLC
13F
Company
3.9%
3,610,412
$29,280,000 31 Mar 2022
13F
MORGAN STANLEY
13F
Company
0.85%
781,712
$6,339,000 31 Mar 2022
13F
BlackRock Finance, Inc.
13F
Company
0.84%
779,820
$6,324,000 31 Mar 2022
13F
KORNITZER CAPITAL MANAGEMENT INC /KS
13F
Company
0.77%
708,976
$5,750,000 31 Mar 2022
13F
VANGUARD GROUP INC
13F
Company
0.75%
692,159
$5,614,000 31 Mar 2022
13F
FMR LLC
13F
Company
0.7%
645,550
$5,235,000 31 Mar 2022
13F
Fosun International Ltd
13F
Company
0.31%
282,408
$2,290,000 31 Mar 2022
13F
STATE STREET CORP
13F
Company
0.25%
231,035
$1,874,000 31 Mar 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.24%
217,398
$1,763,000 31 Mar 2022
13F
NORTHERN TRUST CORP
13F
Company
0.15%
135,956
$1,103,000 31 Mar 2022
13F
SteelPeak Wealth, LLC
13F
Company
0.14%
133,411
$1,082,000 31 Mar 2022
13F
Altium Capital Management LLC
13F
Company
0.11%
97,887
$794,000 31 Mar 2022
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.11%
97,707
$792,000 31 Mar 2022
13F
MML INVESTORS SERVICES, LLC
13F
Company
0.07%
60,500
$491,000 31 Mar 2022
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.06%
55,889
$454,000 31 Mar 2022
13F
Bank of New York Mellon Corp
13F
Company
0.05%
45,807
$372,000 31 Mar 2022
13F
Nuveen Asset Management, LLC
13F
Company
0.04%
32,788
$277,000 31 Mar 2022
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.04%
33,450
$272,000 31 Mar 2022
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.04%
32,817
$266,000 31 Mar 2022
13F
CITADEL ADVISORS LLC
13F
Company
0.03%
29,640
$240,000 31 Mar 2022
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.03%
24,550
$199,000 31 Mar 2022
13F
Tower Research Capital LLC (TRC)
13F
Company
0.02%
19,758
$160,000 31 Mar 2022
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.02%
19,100
$155,000 31 Mar 2022
13F
RHUMBLINE ADVISERS
13F
Company
0.01%
12,769
$104,000 31 Mar 2022
13F
TRUIST FINANCIAL CORP
13F
Company
0.01%
11,298
$92,000 31 Mar 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.01%
10,802
$88,000 31 Mar 2022
13F
A. Brian Davis
3/4/5
Chief Financial Officer
class O/S missing
12,900
$83,721 04 Jun 2021
BECK MACK & OLIVER LLC
13F
Company
0.01%
10,000
$81,000 31 Mar 2022
13F
JPMORGAN CHASE & CO
13F
Company
0.01%
9,367
$76,000 31 Mar 2022
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.01%
8,235
$67,000 31 Mar 2022
13F
DEUTSCHE BANK AG\
13F
Company
0.01%
7,323
$60,000 31 Mar 2022
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.01%
6,502
$53,000 31 Mar 2022
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.01%
5,985
$48,000 31 Mar 2022
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.01%
5,520
$45,000 31 Mar 2022
13F
Allspring Global Investments Holdings, LLC
13F
Company
0.01%
5,111
$41,000 31 Mar 2022
13F
Spire Wealth Management
13F
Company
0%
3,827
$31,000 31 Mar 2022
13F
ROYAL BANK OF CANADA
13F
Company
0%
3,196
$26,000 31 Mar 2022
13F
UBS Group AG
13F
Company
0%
2,810
$23,000 31 Mar 2022
13F
AMALGAMATED BANK
13F
Company
0%
2,133
$17,000 31 Mar 2022
13F
Amalgamated Financial Corp.
13F
Company
0%
2,133
$17,000 31 Mar 2022
13F
BARCLAYS PLC
13F
Company
0%
2,125
$17,000 31 Mar 2022
13F
Legal & General Group Plc
13F
Company
0%
1,437
$12,000 31 Mar 2022
13F
Asset Dedication, LLC
13F
Company
0%
1,193
$10,000 31 Mar 2022
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
1,201
$9,740 31 Mar 2022
13F
Ameritas Investment Partners, Inc.
13F
Company
0%
1,080
$9,000 31 Mar 2022
13F
CITIGROUP INC
13F
Company
0%
1,061
$9,000 31 Mar 2022
13F
EverSource Wealth Advisors, LLC
13F
Company
0%
427
$3,000 31 Mar 2022
13F
STRS OHIO
13F
Company
0%
300
$2,000 31 Mar 2022
13F
GROUP ONE TRADING LLC
13F
Company
0%
200
$2,000 31 Mar 2022
13F

Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q2 2022

As of 30 Jun 2022, Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,327,999 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, FMR LLC, VANGUARD GROUP INC, Point72 Asset Management, L.P., CVI Holdings, LLC, ROYAL BANK OF CANADA, Fosun International Ltd, BlackRock Inc., BANK OF AMERICA CORP /DE/, and Steel Peak Wealth Management LLC. This page lists 51 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
47
Q2 2022 holders
51
Holder diff
4
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 Value $ Q2 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.